Literature DB >> 9458140

Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan.

P De Leyn1, J Vansteenkiste, P Cuypers, G Deneffe, D Van Raemdonck, W Coosemans, J Verschakelen, T Lerut.   

Abstract

OBJECTIVE: The results of primary surgery for non-small cell lung cancer (NSCLC) with involved ipsilateral mediastinal or subcarinal lymph nodes (N2 disease) remains poor. However, several studies suggest that induction chemotherapy could increase long-term survival in patients with N2 disease. Therefore, accurate preoperative staging of the mediastinum remains of paramount importance for the treatment policy in patients with NSCLC. Enlarged mediastinal lymph nodes (MLN) on CT scan are positive in only half of the patients. Small lymph nodes can contain metastatic deposits of clinical importance. However, many surgeons believe that a normal mediastinum at computed tomography allows them to cancel their preoperative mediastinal exploration. It was the aim of this study to evaluate the results of cervical mediastinoscopy in patients without enlarged MLN on CT scan.
METHODS: Between January 1990 and June 1994, 235 patients with potentially operable NSCLC underwent a cervical mediastinoscopy despite the absence of enlarged MLN on CT scan. MLN were considered enlarged if they were equal to or larger than 15 mm at their maximal cross-sectional diameter.
RESULTS: Cervical mediastinoscopy was positive in 47 patients (20%). In 21 patients, N2 disease was extranodal and in 16 patients more than one level was involved. Mediastinoscopy was positive in 9.5% of the cT1N0 cases, in 17.7% of the cT2N0 lesions, in 31.2 and 33.3% of cT3N0 or cT4N0 tumors, respectively. After a negative cervical mediastinoscopy, resectability for unforeseen N2 disease was as high as 95%.
CONCLUSION: We recommend a cervical mediastinoscopy in every patient with potentially operable NSCLC.

Entities:  

Mesh:

Year:  1997        PMID: 9458140     DOI: 10.1016/s1010-7940(97)00253-4

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  15 in total

1.  Perioperative analysis of biopsies issued from mediastinoscopy.

Authors:  M Alifano; M C Charpentier; C Perrotin; T J Molina; P Magdeleinat; J Audouin; J-F Regnard; S Camilleri-Broët
Journal:  Surg Endosc       Date:  2005-09-30       Impact factor: 4.584

2.  Occult pN2 disease in lung cancer patients: a wide range of diseases endangering the long term prognosis.

Authors:  Marc Riquet; Ciprian Pricopi; Giuseppe Mangiameli; Alex Arame; Alain Badia; Françoise Le Pimpec Barthes
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

3.  Heterogeneity Analysis of (18)F-FDG Uptake in Differentiating Between Metastatic and Inflammatory Lymph Nodes in Adenocarcinoma of the Lung: Comparison with Other Parameters and its Application in a Clinical Setting.

Authors:  Hendra Budiawan; Gi Jeong Cheon; Hyung-Jun Im; Soo Jin Lee; Jin Chul Paeng; Keon Wook Kang; June-Key Chung; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2013-08-21

4.  Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients.

Authors:  Andrea Bille; Kaitlin M Woo; Usman Ahmad; Nabil P Rizk; David R Jones
Journal:  Eur J Cardiothorac Surg       Date:  2017-04-01       Impact factor: 4.191

5.  The value of the SUV ratio between lymph node and bone marrow in predicting pelvic lymphatic metastasis of patients with locally advanced cervical cancer: an integrated PET/CT study.

Authors:  Ying Liu; Jun Hua; Lisheng Liu; Wei Zhang; Shufan Xu; Xiaoliang Chen
Journal:  Nucl Med Commun       Date:  2022-08-25       Impact factor: 1.698

Review 6.  Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancer.

Authors:  Henk Kramer; Harry J M Groen
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

Review 7.  Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria.

Authors:  Andrea Caulo; Saeed Mirsadraee; Fabio Maggi; Lucia Leccisotti; Edwin J R van Beek; Lorenzo Bonomo
Journal:  Eur Radiol       Date:  2011-10-04       Impact factor: 5.315

8.  Systematic Video-Assisted Mediastinoscopic Lymphadenectomy (VAMLA).

Authors:  Martin Hürtgen; Godehard Friedel; Biruta Witte; Heikki Toomes; Peter Fritz
Journal:  Thorac Surg Sci       Date:  2005-11-09

9.  Advances in radiological staging of non-small cell lung cancer (NSCLC).

Authors:  S C Rankin
Journal:  Cancer Imaging       Date:  2004-02-14       Impact factor: 3.909

10.  Staging of non-small cell lung cancer (NSCLC).

Authors:  S C Rankin
Journal:  Cancer Imaging       Date:  2006-01-31       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.